Saint Mary’s Hospital celebrated the implementation of the new Siemens Healthineers Atellica Solution, a combined sample management, chemistry and immunoassay testing platform into its laboratory with hospital leadership and Siemens Healthineers representatives. The ground-breaking technology allows for greater efficiency to get physicians the results they need to diagnose and initiate treatment for patients in their care.
Saint Mary's president, Kim Kalajainen, joins the Chemistry Team and Laboratory leaders for a Ribbon Cutting celebrating the implementation of the new Testing Analyzers.
This innovative Atellica technology enables laboratory colleagues to focus on processing samples and clinical outcomes, reducing the time needed to dedicate to managing operations and long maintenance lists. The system provides AI-powered sample management technology and is highly adaptive to the laboratory’s specific patient testing needs. It automatically prioritizes STAT samples without affecting routine workflow. It can also troubleshoot up to 21 days in advance to more conveniently accommodate the maintenance necessary to ensure quality testing.
“We are extremely excited about going live with our new integrated testing analyzer. Our team has worked hard over the last months to prepare for this launch,” said Margaret Jenkins, Laboratory Manager, Saint Mary’s Hospital. “This new technology is a game-changer for our clinicians and ultimately our patients.”
New features allow Saint Mary’s Lab to provide patients and physicians with a faster turnaround time on certain tests such as an 18-minute turnaround time for Procalcitonin (PCT). PCT is a biomarker that helps clinicians in diagnosing and treating bacterial infections. These tests can help determine if a bacteria or virus is causing an infection, which can help guide the need for antibiotic therapy. PCT tests are often used when a patient is seriously ill, and their provider suspects a systemic infection.
“Making a huge investment in the lab is making an investment in our patients and the community,” said Kim Kalajainen, President, Saint Mary’s Hospital. “This state-of-the-art, groundbreaking technology will enable our clinicians to provide better care to our patients, improving outcomes.”